Proficio Capital Partners LLC Incyte Corp Transaction History

Proficio Capital Partners LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 19, 2023	BUY	$70.23 - $86.01 $1.86 Million - $2.28 Million	26,523 New	26,523 $1.92 Million
Q3 2019 Nov 13, 2019	SELL	$72.82 - $86.52 $16,530 - $19,640	-227 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$73.52 - $88.7 $10,733 - $12,950	146 Added 180.25%	227 $19,000
Q1 2019 May 13, 2019	BUY	$63.56 - $88.17 $3,622 - $5,025	57 Added 237.5%	81 $7,000
Q4 2018 Feb 08, 2019	SELL	$58.5 - $69.94 $4,563 - $5,455	-78 Reduced 76.47%	24 $2,000
Q2 2018 Aug 10, 2018	SELL	$60.85 - $83.98 $3,894 - $5,374	-64 Reduced 38.55%	102 $7,000
Q1 2018 May 14, 2018	BUY	$83.06 - $100.98 $2,408 - $2,928	29 Added 21.17%	166 $14,000
Q4 2017 Feb 09, 2018	SELL	$93.56 - $116.6 $9,917 - $12,359	-106 Reduced 43.62%	137 $13,000
Q3 2017 Nov 14, 2017	BUY	$109.15 - $138.27 $26,523 - $33,599	243	243 $28,000

644

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.6B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Proficio Capital Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Proficio Capital Partners LLC with notifications on news.